BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawachi H, Takizawa T, Eishi Y, Shimizu S, Kumagai J, Funata N, Koike M. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol. 2003;199:436-446. [PMID: 12635134 DOI: 10.1002/path.1323] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int. 2004;54:311-321. [PMID: 15086835 DOI: 10.1111/j.1440-1827.2004.01625.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
2 Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype. Scand J Gastroenterol. 2006;41:880-886. [PMID: 16803685 DOI: 10.1080/00365520500497140] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
3 Wada R, Yamaguchi T, Tanizaki T. Mucin phenotypic expression and p53 gene abnormality of gastric super-minute well-differentiated adenocarcinoma: re-evaluation with relationship between histogenesis of well-differentiated adenocarcinoma and intestinal metaplasia in distal stomach. J Carcinog 2005;4:14. [PMID: 16135257 DOI: 10.1186/1477-3163-4-14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Mizoshita T, Tsukamoto T, Tanaka H, Takenaka Y, Kato S, Cao X, Joh T, Tatematsu M. Colonic and small-intestinal phenotypes in gastric cancers: Relationships with clinicopathological findings. Pathol Int 2005;55:611-8. [DOI: 10.1111/j.1440-1827.2005.01878.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
5 Gomceli I, Demiriz B, Tez M. Gastric carcinogenesis. World J Gastroenterol 2012; 18(37): 5164-5170 [PMID: 23066309 DOI: 10.3748/wjg.v18.i37.5164] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
6 Kim GH, Song GA, Park DY, Lee DH, Kim TO, Lee SH, Heo J, Kang DH, Cho M. Clinicopathologic significance of gastric and intestinal phenotypic marker expression in gastric carcinomas. Korean J Intern Med 2005;20:191-7. [PMID: 16295776 DOI: 10.3904/kjim.2005.20.3.191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Yokozaki H, Hasuo T, Li D, Semba S. Adenocarcinoma with Gastric Mucin Phenotype. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 169-81. [DOI: 10.1007/4-431-27713-7_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kakinoki R, Kushima R, Matsubara A, Saito Y, Okabe H, Fujiyama Y, Hattori T. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci. 2009;54:614-620. [PMID: 18709553 DOI: 10.1007/s10620-008-0389-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
9 Kim A, Ahn S, Park DY, Lee B, Song G, Kim GH, Lauwers GY. Gastric crypt dysplasia: a distinct subtype of gastric dysplasia with characteristic endoscopic features and immunophenotypic and biological anomalies. Histopathology 2016;68:843-9. [DOI: 10.1111/his.12860] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004;54:392-400. [PMID: 15144397 DOI: 10.1111/j.1440-1827.2004.01647.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
11 Tatematsu M, Tsukamoto T, Mizoshita T. History of Gastric Carcinoma Research in Japan: Basic Aspects. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 3-28. [DOI: 10.1007/4-431-27713-7_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol. 2003;129:727-734. [PMID: 14557879 DOI: 10.1007/s00432-003-0499-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 5.2] [Reference Citation Analysis]
13 Mills JC, Shivdasani RA. Gastric epithelial stem cells. Gastroenterology 2011;140:412-24. [PMID: 21144849 DOI: 10.1053/j.gastro.2010.12.001] [Cited by in Crossref: 126] [Cited by in F6Publishing: 112] [Article Influence: 10.5] [Reference Citation Analysis]
14 Lennerz JK, Kim SH, Oates EL, Huh WJ, Doherty JM, Tian X, Bredemeyer AJ, Goldenring JR, Lauwers GY, Shin YK. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol. 2010;177:1514-1533. [PMID: 20709804 DOI: 10.2353/ajpath.2010.100328] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
15 Tatematsu M, Tsukamoto T, Mizoshita T. Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter. 2005;10:97-106. [PMID: 15810939 DOI: 10.1111/j.1523-5378.2005.00305.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
16 Hondo FY, Kishi H, Safatle-Ribeiro AV, Pessorrusso FCS, Ribeiro U, Maluf-Filho F. Characterization of the mucin phenotype can predict gastric cancer recurrence after endoscopic mucosal resection. Arq Gastroenterol. 2017;54:308-314. [PMID: 28954038 DOI: 10.1590/s0004-2803.201700000-38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mizoshita T, Tsukamoto T, Cao X, Otsuka T, Ito S, Takahashi E, Nakamura S, Nakamura T, Yamamura Y, Tatematsu M. Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. Gastric Cancer. 2005;8:164-172. [PMID: 16086119 DOI: 10.1007/s10120-005-0331-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tsukamoto T, Mizoshita T, Tatematsu M. Animal models of stomach carcinogenesis. Toxicol Pathol. 2007;35:636-648. [PMID: 17654405 DOI: 10.1080/01926230701420632] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
19 Hasuo T, Semba S, Satake S, Shirasaka D, Aoyama N, Yokozaki H. Superficially elevated-type serrated hyperplastic lesion of the stomach with minute adenocarcinoma. Dig Endosc. 2009;21:101-105. [PMID: 19691783 DOI: 10.1111/j.1443-1661.2009.00831.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
20 Takeo H, Matsukuma S. Gastric tube cancer: immunohistochemical study of 10 lesions in six patients. J Gastroenterol Hepatol 2007;22:23-9. [PMID: 17201876 DOI: 10.1111/j.1440-1746.2006.04466.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
21 Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. Int J Mol Sci 2020;21:E9400. [PMID: 33321820 DOI: 10.3390/ijms21249400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tsukamoto T, Toyoda T, Mizoshita T, Tatematsu M. Helicobacter pylori infection and gastric carcinogenesis in rodent models. Semin Immunopathol. 2013;35:177-190. [PMID: 23111700 DOI: 10.1007/s00281-012-0357-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
23 Hayakawa M, Nishikura K, Ajioka Y, Aoyagi Y, Terai S. Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach. Pathol Int 2017;67:131-40. [PMID: 28088838 DOI: 10.1111/pin.12506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Mihara M, Yoshida Y, Tsukamoto T, Inada K, Nakanishi Y, Yagi Y, Imai K, Sugimura T, Tatematsu M, Ushijima T. Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins. Am J Pathol 2006;169:1643-51. [PMID: 17071588 DOI: 10.2353/ajpath.2006.060552] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
25 Akiyama J, Uemura N. Intestinal metaplasia subtype and gastric cancer risk. Journal of Gastroenterology and Hepatology 2009;24:4-6. [DOI: 10.1111/j.1440-1746.2008.05736.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Okamoto N, Kawachi H, Yoshida T, Kitagaki K, Sekine M, Kojima K, Kawano T, Eishi Y. “Crawling-type” adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma. Gastric Cancer 2013;16:220-32. [DOI: 10.1007/s10120-012-0173-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
27 Rigoli L, Caruso RA. Mitochondrial DNA alterations in the progression of gastric carcinomas: Unexplored issues and future research needs. World J Gastroenterol 2014; 20(43): 16159-16166 [PMID: 25473169 DOI: 10.3748/wjg.v20.i43.16159] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Rokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E, Hosoda F, Yachida S, Tsuji Y, Fujishiro M, Koike K, Totoki Y, Fukayama M, Shibata T. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia. J Pathol. 2019;247:494-504. [PMID: 30474112 DOI: 10.1002/path.5208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
29 Niwa T, Ikehara Y, Nakanishi H, Tanaka H, Inada K, Tsukamoto T, Ichinose M, Tatematsu M. Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem 2005;53:75-85. [PMID: 15637340 DOI: 10.1177/002215540505300109] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
30 Tanaka H, Tsukamoto T, Mizoshita T, Inada K, Ogasawara N, Cao X, Kato S, Joh T, Tatematsu M. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach. Virchows Arch 2005;447:806-15. [PMID: 16088401 DOI: 10.1007/s00428-005-0040-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
31 Domori K, Nishikura K, Ajioka Y, Aoyagi Y. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis. Gastric Cancer. 2014;17:263-272. [PMID: 23828549 DOI: 10.1007/s10120-013-0281-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
32 Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology. 2005;46:649-658. [PMID: 15910596 DOI: 10.1111/j.1365-2559.2005.02170.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.5] [Reference Citation Analysis]
33 Kojima K, Kishimoto T, Nagai Y, Tanizawa T, Nakatani Y, Miyazaki M, Ishikura H. The expression of hepatocyte nuclear factor-4alpha, a developmental regulator of visceral endoderm, correlates with the intestinal phenotype of gastric adenocarcinomas. Pathology. 2006;38:548-554. [PMID: 17393984 DOI: 10.1080/00313020601024011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
34 Shinozaki A, Ushiku T, Morikawa T, Hino R, Sakatani T, Uozaki H, Fukayama M. Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling. J Histochem Cytochem 2009;57:775-85. [PMID: 19398608 DOI: 10.1369/jhc.2009.953810] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
35 Nakano K, Kawachi H, Chino A, Kita M, Arai M, Ide D, Saito S, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Fujisaki J. Phenotypic variations of gastric neoplasms in familial adenomatous polyposis are associated with endoscopic status of atrophic gastritis. Dig Endosc 2020;32:547-56. [PMID: 31411765 DOI: 10.1111/den.13512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Barua RR, Uozaki H, Chong J, Ushiku T, Hino R, Chang M, Nagai H, Fukayama M. Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma. J Gastroenterol 2006;41:733-9. [DOI: 10.1007/s00535-006-1841-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
37 ten Dam GB, Poels LG, Pullens R, Jap PH, van de Molengraft FJ. Expression of a colorectal antigen defined by a new monoclonal antibody, CO-TL1. Lab Invest 2004;84:1160-73. [PMID: 15195115 DOI: 10.1038/labinvest.3700130] [Reference Citation Analysis]